Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Towards patient-based cancer therapeutics

Orienting cancer drug discovery to the patient requires relating the genetic features of tumors to acquired gene and pathway dependencies and identifying small-molecule therapeutics that target them.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The NCI's Cancer Target Discovery and Development (CTD2) Network aims to relate the genetic features of cancers to acquired cancer dependencies and to identify small molecules that target the dependencies.
Figure 2: Conceptual image of a matrix of data relating cancer genotype, cancer phenotype and sensitivity to highly specific small-molecule modulators of cancer-relevant proteins.

References

  1. Weinstein, I.B. & Joe, A.K. Nat. Clin. Pract. Oncol. 3, 448–457 (2006).

    Article  CAS  Google Scholar 

  2. Aggarwal, S. Nat. Rev. Drug Discov. 9, 427–428 (2010).

    Article  CAS  Google Scholar 

  3. Thompson, C.B. Cell 138, 1051–1054 (2009).

    Article  CAS  Google Scholar 

  4. Bach, P.B. N. Engl. J. Med. 360, 626–633 (2009).

    Article  CAS  Google Scholar 

  5. Luo, J., Solimini, N.L. & Elledge, S.J. Cell 136, 823–837 (2009).

    Article  CAS  Google Scholar 

  6. Whitehurst, A.W. et al. Nature 446, 815–819 (2007).

    Article  CAS  Google Scholar 

  7. Barbie, D.A. et al. Nature 462, 108–112 (2009).

    Article  CAS  Google Scholar 

  8. Carro, M.S. et al. Nature 463, 318–325 (2010).

    Article  CAS  Google Scholar 

  9. Deininger, M.W., Goldman, J.M., Lydon, N. & Melo, J.V. Blood 90, 3691–3698 (1997).

    CAS  PubMed  Google Scholar 

  10. McDermott, U. et al. Proc. Natl. Acad. Sci. USA 104, 19936–19941 (2007).

    Article  CAS  Google Scholar 

  11. Ramanathan, A., Wang, C. & Schreiber, S.L. Proc. Natl. Acad. Sci. USA 102, 5992–5997 (2005).

    Article  CAS  Google Scholar 

  12. Frye, S.V. Nat. Chem. Biol. 6, 159–161 (2010).

    Article  CAS  Google Scholar 

  13. Workman, P. & Collins, I. Chem. Biol. 17, 561–577 (2010).

    Article  CAS  Google Scholar 

  14. Lin, W.M. et al. Cancer Res. 68, 664–673 (2008).

    Article  CAS  Google Scholar 

  15. Sos, M.L. et al. J. Clin. Invest. 119, 1727–1740 (2009).

    Article  CAS  Google Scholar 

  16. Lee, J. et al. Cancer Cell 9, 391–403 (2006).

    Article  CAS  Google Scholar 

  17. van Staveren, W.C. et al. Biochim. Biophys. Acta 1795, 92–103 (2009).

    CAS  PubMed  Google Scholar 

  18. Turke, A.B. et al. Cancer Cell 17, 77–88 (2010).

    Article  CAS  Google Scholar 

  19. Zender, L. et al. Cell 125, 1253–1267 (2006).

    Article  CAS  Google Scholar 

  20. Zheng, H. et al. Nature 455, 1129–1133 (2008).

    Article  CAS  Google Scholar 

  21. Zuber, J. et al. Genes Dev. 23, 877–889 (2009).

    Article  CAS  Google Scholar 

  22. Zender, L. et al. Cell 135, 852–864 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Stuart L Schreiber.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

The Cancer Target Discovery and Development Network., Schreiber, S., Shamji, A. et al. Towards patient-based cancer therapeutics. Nat Biotechnol 28, 904–906 (2010). https://doi.org/10.1038/nbt0910-904

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0910-904

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer